Øystein Kalsnes Jørstad (Øystein K Jørstad)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 19

Top Topics

Diabetic Retinopathy

Quality Improvement

Optical Coherence Tomography

Top Venues

Acta ophthalmologica

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

BMJ open ophthalmology

This page only lists publications with an associated author ORCID identifier.

Publications

Henning Yu Nilsen, Anna-Katharina Litzen Jørstad, Stephen James Ryan, Morten Carstens Moe, Kristoffer Grimstad, Anne Hege Aamodt, Trygve Holmøy, Øystein Kalsnes Jørstad
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 143 (16) (2023)
Ellen Steffenssen Sauesund, Øystein Kalsnes Jørstad, Cathrine Brunborg, Morten Carstens Moe, Maja Gran Erke, Dag Sigurd Fosmark, Goran Petrovski
A Pilot Study of Implementing Diabetic Retinopathy Screening in the Oslo Region, Norway: Baseline Results. Biomedicines 11 (4) (2023)
Ellen Steffenssen Sauesund, Øystein Kalsnes Jørstad, Cathrine Brunborg, Morten Carstens Moe, Maja Gran Erke, Dag Sigurd Fosmark, Goran Petrovski
A Pilot Study of Implementing Diabetic Retinopathy Screening in the Oslo Region, Norway: Baseline Results. Biomedicines 11 (4) (2023)
Yngvil Solheim Husum, Ragnhild Haugli Bråten, Erik Magnus Saether, Morten Carstens Moe, Ivar Sønbø Kristiansen, Øystein Kalsnes Jørstad
Intravitreal anti-vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study. Acta ophthalmologica (2023)
Øystein Kalsnes Jørstad, Stian Foss, Torleif Tollefsrud Gjølberg, Simone Mester, Mari Nyquist-Andersen, Magne Sand Sivertsen, Dag Fossum, Espen Gleditsch, Morten Carstens Moe, Jan Terje Andersen
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. International journal of retina and vitreous 9 (1) (2023)
Silvia Nanjala Walekhwa Hertzberg, Øystein Kalsnes Jørstad, Beáta Éva Petrovski, Ragnheidur Bragadottir, Leif Arthur Steffensen, Morten Carstens Moe, Emily A Burger, Goran Petrovski
Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare Perspective. International journal of environmental research and public health 19 (19) (2022)
Thea Melsen Sudmann, Anne Brækhus, Øystein Kalsnes Jørstad
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 142 (16) (2022)
Thea Melsen Sudmann, Thora Elisabet Jonsdottir, Fiona J Rowe, Øystein Kalsnes Jørstad
National application of the European visual field standards for driving: a survey study. BMJ open ophthalmology 7 (1) (2022)
null null, Øystein Kalsnes Jørstad, Anne Kongsrud, Bettina Kinge, Kristian Fossen, Sammy Basit, Vegard Asgeir Forsaa, Morten Carstens Moe, Olav Henrik Haugen
Choosing Wisely: recommendations from the Norwegian Ophthalmological Society. Acta ophthalmologica 100 (6) (2021)
Yngvil Solheim Husum, Morten Carstens Moe, Ragnheiður Bragadóttir, Øystein Kalsnes Jørstad
Switching to aflibercept versus continuing bevacizumab for treatment-resistant neovascular age-related macular degeneration: a one-year comparative observational study. Acta ophthalmologica 99 (8) (2021)
Øystein Kalsnes Jørstad, Thora Elisabet Jonsdottir, Stefan Zysset, Fiona J Rowe
A traffic perimetry test that adheres to the European visual field requirements for group 2 drivers. Acta ophthalmologica 99 (7) (2021)
Øystein Kalsnes Jørstad, Morten Carstens Moe, Ketil Eriksen, Goran Petrovski, Ragnheiður Bragadóttir
Coronavirus disease 2019 (COVID-19) outbreak at the Department of Ophthalmology, Oslo University Hospital, Norway. Acta ophthalmologica 98 (3) (2020)
Kathrine Blom, Ragnheiður Bragadóttir, Magne Sand Sivertsen, Morten Carstens Moe, Øystein Kalsnes Jørstad
Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis? Ocular immunology and inflammation (2020)
Øystein Kalsnes Jørstad, Thora Elisabet Jonsdottir, Stefan Zysset, Fiona J Rowe
A traffic perimetry test that adheres to the European visual field requirements. Acta ophthalmologica 99 (4) (2020)
Øystein Kalsnes Jørstad, Andreas Reidar Wigers, Pål Bache Marthinsen, Johan Arild Evang, Morten Carstens Moe
Could optical coherence tomography add to the history of the pituitary incidentaloma? Acta ophthalmologica 97 (8) (2019)
Øystein Kalsnes Jørstad, Leif Arthur Steffensen, Ketil Eriksen, Ragnheiður Bragadóttir, Morten Carstens Moe
Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in Norway. Acta ophthalmologica 98 (8) (2019)
Tomas Bro, Magdalena Derebecka, Øystein Kalsnes Jørstad, Andrzej E Grzybowski
Off-label use of bevacizumab for wet age-related macular degeneration in Europe. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 258 (3) (2019)
Cato Innerdal, Julian Raffael Ekstrand, Vibeke Dons Wankel, Øystein Kalsnes Jørstad
Visual field requirements for driving in Europe: the risk of inaccurate interpretation of visual field findings when using the binocular Esterman programme. Acta ophthalmologica 97 (6) (2019)
Ivar Sønbø Kristiansen, Ragnhild Haugli Bråten, Øystein Kalsnes Jørstad, Morten Carstens Moe, Erik Magnus Saether
Intravitreal therapy for retinal diseases in Norway 2011-2015. Acta ophthalmologica 98 (3) (2019)